Stock Chart

()

$

(0%)

WSNAF Company Profile

,

Sector:
Industry:
Full Time Employees:

Previous Close
Open

0.027
Bid
Ask
Day's Range

0.027 - 0.0324
52 week Range

-
Volume

40523
Avg. Volume

Market Cap
Beta (5Y Monthly)
PE Ratio (TTM)
EPS (TTM)
Earnings Date
Forward Dividend & Yield
Ex-Dividend Date
1y Target Est

KEEP ME INFORMED ON WSNAF UPDATES

WSNAF Performance

5 Day

0%
1 Month

0%
3 Month

0%
YTD

0%
1 Year

0%

WSNAF on Twitter

AAA

Wed, Feb 8, 3:44 pm

RT @MicrodoseHQ: Weekly closers in #psychedelic #stocks- $NM +46.51% $COOL +38.75% $WSNAF +36.13% $WESA +31.51% $FTRP +27.41% $HAVN +20% $M…
T

Wed, Feb 8, 5:18 am

RT @MicrodoseHQ: Weekly closers in #psychedelic #stocks- $NM +46.51% $COOL +38.75% $WSNAF +36.13% $WESA +31.51% $FTRP +27.41% $HAVN +20% $M…
YeMoFerFery

Tue, Feb 7, 4:13 pm

RT @MicrodoseHQ: Mid-week movers in #psychedelic #stocks- $NM +13.79% $HAVN +10% $MMED +7.81% $BETR +6.90% $PHRM +6.82% $CMPS +5.83% $MNMD…
konrad

Tue, Feb 7, 4:11 pm

RT @MicrodoseHQ: Weekly closers in #psychedelic #stocks- $NM +46.51% $COOL +38.75% $WSNAF +36.13% $WESA +31.51% $FTRP +27.41% $HAVN +20% $M…
SwingTradeBot OTC

Tue, Feb 7, 11:01 am

Rose Above Previous Day's High today: $WSNAF $ROYMF $HEGIY $VAYK $RLTR $IHCNF ... https://t.co/O6UPMJnowZ
FonDeWdle🧪

Mon, Feb 6, 12:51 pm

RT @MicrodoseHQ: Weekly closers in #psychedelic #stocks- $NM +46.51% $COOL +38.75% $WSNAF +36.13% $WESA +31.51% $FTRP +27.41% $HAVN +20% $M…
Matt Greene

Mon, Feb 6, 2:34 am

RT @MicrodoseHQ: Weekly closers in #psychedelic #stocks- $NM +46.51% $COOL +38.75% $WSNAF +36.13% $WESA +31.51% $FTRP +27.41% $HAVN +20% $M…
Joe Gambiste

Sun, Feb 5, 4:54 am

RT @MicrodoseHQ: Weekly closers in #psychedelic #stocks- $NM +46.51% $COOL +38.75% $WSNAF +36.13% $WESA +31.51% $FTRP +27.41% $HAVN +20% $M…
Kaboom_0x

Sun, Feb 5, 4:39 am

RT @MicrodoseHQ: Weekly closers in #psychedelic #stocks- $NM +46.51% $COOL +38.75% $WSNAF +36.13% $WESA +31.51% $FTRP +27.41% $HAVN +20% $M…
Mike Patch

Sat, Feb 4, 8:46 pm

RT @MicrodoseHQ: Weekly closers in #psychedelic #stocks- $NM +46.51% $COOL +38.75% $WSNAF +36.13% $WESA +31.51% $FTRP +27.41% $HAVN +20% $M…
BlueSparrow

Sat, Feb 4, 2:13 pm

RT @MicrodoseHQ: Weekly closers in #psychedelic #stocks- $NM +46.51% $COOL +38.75% $WSNAF +36.13% $WESA +31.51% $FTRP +27.41% $HAVN +20% $M…
Mushtaq Bhalli

Sat, Feb 4, 12:29 pm

RT @MicrodoseHQ: Weekly closers in #psychedelic #stocks- $NM +46.51% $COOL +38.75% $WSNAF +36.13% $WESA +31.51% $FTRP +27.41% $HAVN +20% $M…
nori

Sat, Feb 4, 11:44 am

RT @MicrodoseHQ: Weekly closers in #psychedelic #stocks- $NM +46.51% $COOL +38.75% $WSNAF +36.13% $WESA +31.51% $FTRP +27.41% $HAVN +20% $M…
CatCallingYourPuts

Fri, Feb 3, 6:25 pm

RT @MicrodoseHQ: Weekly closers in #psychedelic #stocks- $NM +46.51% $COOL +38.75% $WSNAF +36.13% $WESA +31.51% $FTRP +27.41% $HAVN +20% $M…
GRANDmasterFLIP

Fri, Feb 3, 12:59 pm

RT @MicrodoseHQ: Weekly closers in #psychedelic #stocks- $NM +46.51% $COOL +38.75% $WSNAF +36.13% $WESA +31.51% $FTRP +27.41% $HAVN +20% $M…

Stock Chart

Stock Chart

()

$

WSNAF Company Profile

KEEP ME INFORMED ON WSNAF UPDATES

WSNAF Performance

WSNAF on Twitter

WSNAF on iHub

WSNAF News

Wesana Health Announces Receipt of Short-Term Loan

Wesana Announces Sale of Clinic Management Services Organization

Wesana Announces Second Quarter 2022 Financial Results

Fresh New Market Movers: Today’s Top Stock Picks for New & Trending Opportunities

Wesana Health CEO Daniel Carcillo to Keynote Charles River Symposium: Re-Imagining Substance Abuse, Addiction, and Mental Health Disorders with Psychedelic Therapies

Wesana Announces First Quarter 2022 Financial Results

Wesana Health Outlines Accelerated Drug Development Pathway

Wesana Announces Singular Focus on Drug Development Prompting a Strategic Review of its Clinics and Other Care Delivery Assets

Wesana Health Reports Q4 2021 Financial Results and Provides Subsequent Period Highlights

KCSA Psychedelics Virtual Investor Conference Presentations Now Available for On-Demand Viewing

Wesana Health to Present Live at KCSA Virtual Investor Conference April 28th

Wesana Is Exploring Broadening SANA-013 Lead Indication to Treat Major Depressive Disorder

Wesana Health CEO Daniel Carcillo to Speak at Several Leading Investor and Industry Events

Wesana Health Announces New Findings Indicating Psylocibin Potentiates Impact of an Anti-Depressant

Wesana Health Announces Positive Feedback From Pre-IND Meeting With FDA on SANA-013

Wesana Provides Updates on Build-out of Third Clinic